Cover Image

Effectiveness of tisagenlecleucel versus real-world standard of care in relapsed/refractory follicular lymphoma

Aim: To contextualize the effectiveness of tisagenlecleucel versus real-world standard of care (SoC) in relapsed/refractory follicular lymphoma. Materials & methods: A retrospective indirect matched comparison study using data from the phase II ELARA trial and the US Flatiron Health Research Dat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yanni Hao (Author), Wei-Chun Hsu (Author), Craig S Parzynski (Author), Evgeny Degtyarev (Author), Lisa V Hampson (Author), Aisha Masood (Author), Wen-Hsing Wu (Author)
Format:	Book
Published:	Becaris Publishing Limited, 2023-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cost-utility and value of information analysis of tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma in the Irish healthcare setting
by: Niamh Carey, et al.
Published: (2023)

CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia
by: Vairy S, et al.
Published: (2018)

Cost-effectiveness of obinutuzumab plus bendamustine in Chinese patients with relapse and refractory follicular lymphoma
by: Jun Ma, et al.
Published: (2023)

Cost-Effectiveness Analysis of Tisagenlecleucel in the Treatment of Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia in Children and Young Adults in Spain
by: Ribera Santasusana JM, et al.
Published: (2020)

Vesiculobullous eruption with loncastuximab tesirine in a patient with relapsed follicular lymphoma
by: Riyad N.H. Seervai, MD, PhD, et al.
Published: (2024)

Brentuximab vedotin for relapsed or refractory Hodgkin’s lymphoma
by: Chen R, et al.
Published: (2015)

Cost-Effectiveness and Budget Impact Analyses of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia from the Singapore Healthcare System Perspective
by: Wang XJ, et al.
Published: (2022)

Role of brentuximab vedotin in the treatment of relapsed or refractory Hodgkin lymphoma
by: Siddiqi T, et al.
Published: (2014)

Case report: Tisagenlecleucel for treatment of relapsed B- acute lymphoblastic leukemia in a patient with CHEK2 mutation
by: Abraham Ipe, et al.
Published: (2023)

Tisagenlecleucel in Children and Young Adults: Reverse Translational Research by Using Real-World Safety Data
by: Concetta Rafaniello, et al.
Published: (2020)

The role of dermatoscopy and reflectance confocal microscopy in the assessment of relapsing secondary cutaneous follicular B-cell lymphoma
by: Alessandro Laghi, MD, et al.
Published: (2022)

Relapsed and refractory classical Hodgkin lymphoma: could virotherapy help solve the equation?
by: Selma Addou, et al.
Published: (2021)

COST-EFFECTIVENESS ANALYSIS OF BRENTUXIMAB VEDOTIN IN ADULTS WITH RELAPSED OR REFRACTORY HODGKIN'S LYMPHOMA
by: G. R. Khachatryan, et al.
Published: (2016)

Kinase Inhibition in Relapsed/Refractory Leukemia and Lymphoma Settings: Recent Prospects into Clinical Investigations
by: Caio Bezerra Machado, et al.
Published: (2021)

Ibrutinib in Refractory or Relapsing Primary Central Nervous System Lymphoma: A Systematic Review
by: Gaurav Nepal, et al.
Published: (2022)

Management of Relapsed/Refractory Epithelial Ovarian Cancer: Current Standards and Novel Approaches
by: Hao Lin, et al.
Published: (2007)

A rare face of follicular lymphoma: reverse variant of follicular lymphoma
by: Ninu Maskey, et al.
Published: (2020)

A case of genital pyoderma gangrenosum successfully treated with cyclosporine without relapse of established follicular lymphoma
by: Lisa Roche, MBBCh, BAO, et al.
Published: (2018)

Systematic review of outcomes and patient heterogeneity in relapsed or refractory diffuse large B-cell lymphoma
by: Sally D Miller, et al.
Published: (2022)

Outcome of pediatric relapsed refractory Hodgkin lymphoma experience from Tata Memorial Hospital , Mumbai
by: Ankita Pandey, et al.
Published: (2022)

Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myeloma
by: Shang-Yi Huang, et al.
Published: (2019)

Potentials of brentuximab vedotin in the treatment of relapse/refractory cutaneous T-cell lymphomas: literature review and authors' observation
by: L. G. Gorenkova, et al.
Published: (2019)

Follicular T-Cell Lymphoma with Concomitant Lennert Lymphoma
by: Seungkyu Choi, et al.
Published: (2018)

Composite follicular lymphoma and classic Hodgkin lymphoma
by: Han-Na Kim, et al.
Published: (2022)

Pomalidomide Treatment in Relapsed/Refractory Multiple Myeloma Patients-Real-World Data From Hungary
by: Szilvia Lovas, et al.
Published: (2022)

Primary testicular follicular lymphoma
by: Sofia Garces, et al.
Published: (2022)

Pediatric-type follicular lymphoma
by: Anuj Verma, et al.
Published: (2022)

Follicular lymphoma: updates for pathologists
by: Mahsa Khanlari, et al.
Published: (2022)

Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B‐cell non‐Hodgkin lymphoma
by: Brendan Bender, et al.
Published: (2024)

Kymriah® (tisagenlecleucel) - An overview of the clinical development journey of the first approved CAR-T therapy
by: Rakesh Awasthi, et al.
Published: (2023)

Tisagenlecleucel Model‐Based Cellular Kinetic Analysis of Chimeric Antigen Receptor-T Cells
by: Andrew M. Stein, et al.
Published: (2019)

Atypical burkitt's lymphoma transforming from follicular lymphoma
by: Chung Lap P, et al.
Published: (2011)

Novel Therapies for Relapsed and Refractory Neuroblastoma
by: Peter E. Zage
Published: (2018)

Harnessing natural killer cells for refractory/relapsed non-Hodgkin lymphoma: biological roles, clinical trials, and future prospective
by: Mehdi Bakhtiyaridovvombaygi, et al.
Published: (2024)

Against the odds: Managing pediatric relapsed/refractory Hodgkin lymphoma with autologous stem cell transplant in resource-limited settings
by: Sanjana Sarangarajan, et al.
Published: (2024)

Large B-cell lymphoma with IRF4 rearrangement and follicular Pattern: A differential diagnosis of follicular lymphoma
by: Do Hwan Kim, et al.
Published: (2022)

Smad1 Expression in Follicular Lymphoma
by: Jai Hyang Go
Published: (2015)

Follicular variant of peripheral T-cell lymphoma
by: Archana Lakshmanan, et al.
Published: (2017)

Generalized granuloma annulare heralding relapse of non-Hodgkin lymphoma
by: Sarah A. King, MEng, et al.
Published: (2020)

Teclistamab versus real-world physician's choice of therapy in triple-class exposed relapsed/refractory multiple myeloma
by: Amrita Krishnan, et al.
Published: (2023)